These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8638708)

  • 1. Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase.
    Mourelle M; Vilaseca J; Guarner F; Salas A; Malagelada JR
    Am J Physiol; 1996 Mar; 270(3 Pt 1):G425-30. PubMed ID: 8638708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats.
    Onori L; Aggio A; D'Alo' S; Muzi P; Cifone MG; Mellillo G; Ciccocioppo R; Taddei G; Frieri G; Latella G
    World J Gastroenterol; 2005 Sep; 11(36):5677-84. PubMed ID: 16237764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in spontaneous contractions in vitro after repeated inflammation of rat distal colon.
    Bossone C; Hosseini JM; Piñeiro-Carrero V; Shea-Donohue T
    Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G949-57. PubMed ID: 11292604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing effects of two nitric oxide synthase inhibitors on experimental colitis.
    Yamaguchi T; Yoshida N; Ichiishi E; Sugimoto N; Naito Y; Yoshikawa T
    Hepatogastroenterology; 2001; 48(37):118-22. PubMed ID: 11268945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats.
    Pfeiffer CJ; Qiu BS
    J Pharm Pharmacol; 1995 Oct; 47(10):827-32. PubMed ID: 8583351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective beneficial effects of nitric oxide inhibition in experimental colitis.
    Hogaboam CM; Jacobson K; Collins SM; Blennerhassett MG
    Am J Physiol; 1995 Apr; 268(4 Pt 1):G673-84. PubMed ID: 7537457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of iNOS mRNA associated with suppression of colonic contraction in rat colitis.
    Lundberg S; Holst M; Hellström PM
    Acta Physiol (Oxf); 2006 Aug; 187(4):489-94. PubMed ID: 16866779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent actions of nitric oxide synthase inhibition on colonic inflammation induced by trinitrobenzene sulphonic acid in rats.
    Kiss J; Lamarque D; Delchier JC; Whittle BJ
    Eur J Pharmacol; 1997 Oct; 336(2-3):219-24. PubMed ID: 9384236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of inducible nitric oxide synthase inhibitors reduces nitric oxide synthesis but has no effect on the severity of experimental colitis.
    Armstrong AM; Campbell GR; Gannon C; Kirk SJ; Gardiner KR
    Scand J Gastroenterol; 2000 Aug; 35(8):832-8. PubMed ID: 10994622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine.
    Scott JA; Machoun M; McCormack DG
    J Appl Physiol (1985); 1996 Jan; 80(1):271-7. PubMed ID: 8847314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
    Rachmilewitz D; Karmeli F; Okon E; Bursztyn M
    Gut; 1995 Aug; 37(2):247-55. PubMed ID: 7557576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute experimental colitis decreases colonic circular smooth muscle contractility in rats.
    Myers BS; Martin JS; Dempsey DT; Parkman HP; Thomas RM; Ryan JP
    Am J Physiol; 1997 Oct; 273(4):G928-36. PubMed ID: 9357837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nitric oxide synthase inhibition or sulfasalazine on the spontaneous colitis observed in HLA-B27 transgenic rats.
    Aiko S; Fuseler J; Grisham MB
    J Pharmacol Exp Ther; 1998 Feb; 284(2):722-7. PubMed ID: 9454820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway.
    Heydarpour P; Rahimian R; Fakhfouri G; Khoshkish S; Fakhraei N; Salehi-Sadaghiani M; Wang H; Abbasi A; Dehpour AR; Ghia JE
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():131-41. PubMed ID: 26268932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism underlying the reversal of contractility dysfunction in experimental colitis by cyclooxygenase-2 inhibition.
    Khan I; Oriowo MA
    Inflammopharmacology; 2006 Mar; 14(1-2):28-35. PubMed ID: 16835710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production.
    Yue G; Lai PS; Yin K; Sun FF; Nagele RG; Liu X; Linask KK; Wang C; Lin KT; Wong PY
    J Pharmacol Exp Ther; 2001 Jun; 297(3):915-25. PubMed ID: 11356911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of inducible nitric oxide synthase in smooth muscle cells from rat penile corpora cavernosa.
    Hung A; Vernet D; Xie Y; Rajavashisth T; Rodríguez JA; Rajfer J; González-Cadavid NF
    J Androl; 1995; 16(6):469-81. PubMed ID: 14959705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.
    Dudhgaonkar SP; Tandan SK; Kumar D; Raviprakash V; Kataria M
    Inflammopharmacology; 2007 Oct; 15(5):188-95. PubMed ID: 17943250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis.
    Ferretti M; Gionchetti P; Rizzello F; Venturi A; Stella P; Corti F; Mizrahi J; Miglioli M; Campieri M
    Dig Dis Sci; 1997 Dec; 42(12):2606-11. PubMed ID: 9440646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological role of nitric oxide in rat experimental colitis.
    Southey A; Tanaka S; Murakami T; Miyoshi H; Ishizuka T; Sugiura M; Kawashima K; Sugita T
    Int J Immunopharmacol; 1997; 19(11-12):669-76. PubMed ID: 9669207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.